06.12.2022 - 08.12.2022Hyatt Regency Boston, 1 Avenue de Lafayette, Massachusetts, 02111 Boston, USA
Time: 09:00 to 16:00
Temi della conferenza Enhance Your Prediction of PKPD, Accurate Dosing Regime and Immuno-Modulation of LNP for Long-Term Patient Safety and Potency
Following the success of LNP-mRNA vaccines, we have seen an influx of novel types of lipids based nanocarriers over the last 12 months, progress has been made to minimize immuno-toxicity challenges – from maximizing therapeutic window to fine-tuning the immune response.
Professional congress organizer (PCO) Molly Sullivan
Speakers: Vibha Jawa, Executive Director, Bristol Myers Squibb, Tao Niu, Associate Director, Modeling and Simulations, Vertex Pharmaceuticals, and more